Medicine & Life Sciences
Radiation
100%
Prostatic Neoplasms
78%
Radiation Exposure
58%
Valproic Acid
55%
Prostate
54%
Metformin
54%
Bystander Effect
53%
Spleen
50%
Adenocarcinoma
49%
Apoptosis
43%
Transgenic Mice
41%
parthenolide
40%
X-Rays
39%
DNA Methylation
37%
Genetic Recombination
33%
Methylation
33%
Intracisternal A-Particle Genes
30%
Neoplasms
30%
Radiation Protection
25%
Familial Breast Cancer
23%
Ionizing Radiation
23%
Androgen Receptors
23%
MicroRNAs
21%
Annexin A1
18%
Amifostine
18%
Annexins
17%
Tritium
16%
Radiotherapy
16%
Breast Neoplasms
16%
Ribosomal Proteins
16%
Nomograms
15%
Adoptive Transfer
14%
Watchful Waiting
14%
Radiation Tolerance
14%
Autoantigens
14%
Androgens
13%
Interleukins
13%
In Situ Nick-End Labeling
13%
Pharmaceutical Preparations
13%
Prostatectomy
13%
Complementary DNA
12%
Viral Tumor Antigens
12%
Immunoassay
12%
Nucleic Acids
12%
Autophagy
12%
Long Interspersed Nucleotide Elements
12%
Cornea
11%
Autoantibodies
11%
Sheep
11%
Galactosidases
11%
Physics & Astronomy
dosage
90%
mice
89%
spleen
81%
radiation
72%
radiation dosage
67%
apoptosis
44%
cancer
38%
radiation therapy
32%
radiation tolerance
27%
tumors
25%
methylation
23%
cultured cells
20%
damage
18%
deoxyribonucleic acid
17%
irradiation
16%
promotion
15%
serums
15%
inversions
13%
tritium
13%
mutations
12%
testes
11%
cells
10%
glutathione
9%
therapy
9%
ribosomes
9%
ionizing radiation
8%
genes
8%
drugs
8%
sensitivity
7%
metabolism
7%
thymidine
6%
drinking
6%
fibrosis
5%
screening
5%
biological effects
5%
Agriculture & Biology
gene therapy
36%
allografting
32%
mice
30%
cornea
27%
neoplasms
21%
prostatic neoplasms
19%
sheep
17%
interleukin-12
17%
myeloma
16%
genes
16%
spleen
15%
interleukin-4
15%
transgenes
14%
breast neoplasms
14%
genetically modified organisms
14%
mutagenesis
13%
blood cells
13%
bone marrow
13%
carcinogenesis
13%
DNA methylation
13%
stem cells
12%
genetic instability
12%
dosage
11%
nucleic acids
11%
T-lymphocytes
11%
etoposide
11%
cells
10%
gene transfer
10%
methylation
10%
irradiation
10%
tissues
10%
staining
9%
adenocarcinoma
9%
graft rejection
9%
receptors
8%
galactosidases
6%
acetamides
6%
oncogenes
6%
apoptosis
6%
antigens
6%
mutation
5%
endothelium
5%
animal models
5%
assays
5%
mutation rate
5%
DNA
5%
promoter regions
5%